Monday, January 13, 2025
HomeTagsMyOme

MyOme

Natera & MyOme Launch iPRS for Breast Cancer Risk

Natera, Inc, a global leader in cell-free DNA and genetic testing, and MyOme, a leading clinical whole genome analysis and polygenic risk modeling company,...

MyOme Secures $23M in Series B Funding to Deliver Clinical Whole Genome Insights to Help Families Manage Risk for Inherited Diseases

MyOme, a clinical whole genome platform analysis company, announced that the company has raised $23 million in an oversubscribed series B financing round led...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics